The Tricuspid Flow Optimizer was developed by Triflo Cardiovascular, a U.S.-based healthcare technology company founded by structural heart specialists.
During valve-in-valve TMVR, patients are treated with conscious sedation or monitored anesthesia care instead of general anesthesia. This new analysis confirms that the change does not impact patient outcomes, but it was linked to a shorter length of stay.
A new trial for participants from 16 church groups in Minnesota showed that app users significantly improved their heart health scores after just 10 weeks.
Limiting salt is a common recommendation for patients hoping to improve their heart health or lose weight. According to a new analysis of more than 1,700 patients, however, going too far with such restrictions can lead to worse outcomes.
The study's authors explored data from 35 patients who received the TricValve Transcatheter Bicaval Valves System. All patients presented with severe tricuspid regurgitation.
Focused rotary jet spinning appears to hold some key advantages over 3D printing and other techniques. Engineers at Harvard think it could represent the future of organ biofabrication.
The study's authors noted that the ECG acquisition technology in these wearable devices appears to be quite effective. The automated algorithms, however, could still be improved.